These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 9619779

  • 1. P-glycoprotein is more efficient at limiting uptake than inducing efflux of colchicine and vinblastine in HL-60 cells.
    Declèves X, Chappey O, Boval B, Niel E, Scherrmann JM.
    Pharm Res; 1998 May; 15(5):712-8. PubMed ID: 9619779
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice.
    Cisternino S, Rousselle C, Dagenais C, Scherrmann JM.
    Pharm Res; 2001 Feb; 18(2):183-90. PubMed ID: 11405289
    [Abstract] [Full Text] [Related]

  • 5. In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier.
    Cisternino S, Rousselle C, Debray M, Scherrmann JM.
    Pharm Res; 2003 Oct; 20(10):1607-11. PubMed ID: 14620515
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine.
    Ogihara T, Kamiya M, Ozawa M, Fujita T, Yamamoto A, Yamashita S, Ohnishi S, Isomura Y.
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):238-44. PubMed ID: 16858128
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier.
    Matsuzaki J, Yamamoto C, Miyama T, Takanaga H, Matsuo H, Ishizuka H, Kawahara Y, Kuwano M, Naito M, Tsuruo T, Sawada Y.
    Biopharm Drug Dispos; 1999 Mar; 20(2):85-90. PubMed ID: 10206323
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin.
    Pouliot JF, L'Heureux F, Liu Z, Prichard RK, Georges E.
    Biochem Pharmacol; 1997 Jan 10; 53(1):17-25. PubMed ID: 8960059
    [Abstract] [Full Text] [Related]

  • 12. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells.
    Regina A, Koman A, Piciotti M, El Hafny B, Center MS, Bergmann R, Couraud PO, Roux F.
    J Neurochem; 1998 Aug 10; 71(2):705-15. PubMed ID: 9681461
    [Abstract] [Full Text] [Related]

  • 13. Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter.
    Döppenschmitt S, Spahn-Langguth H, Regårdh CG, Langguth P.
    Pharm Res; 1998 Jul 10; 15(7):1001-6. PubMed ID: 9688051
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.
    Takanaga H, Ohnishi A, Matsuo H, Sawada Y.
    Biol Pharm Bull; 1998 Oct 10; 21(10):1062-6. PubMed ID: 9821810
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system.
    Nakayama A, Saitoh H, Oda M, Takada M, Aungst BJ.
    Eur J Pharm Sci; 2000 Oct 10; 11(4):317-24. PubMed ID: 11033075
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.